pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

14,268 catalysts · 3,350 8k filing · 2,402 grant · 2,350 approval · 1,681 device 510k · 1,204 device recall · 1,151 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2025-10-02×clear all
type
  • 8k filing3,350
  • grant2,402
  • approval2,350
  • device 510k1,681
  • device recall1,204
  • device pma1,151
device adverse event
1,000
  • earnings584
  • recall465
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Oct 27, 2025

    38
    ›Oct 31, 2025device recall289d agoPhilips North America Llc device recall (Cls II)

    IntelliVue Patient Monitor MX600. Product Number: 865242. — Reason: Potential issue where the IntelliVue monitors did not alarm. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 31, 2025device recall289d agoStryker Medical Division of Stryker Corporation device recall (Cls II)

    Stryker Arise 1000EX mattress, Part Number 2236000000 — Reason: Stryker has issued a voluntary recall of certain MV3 beds and Arise 1000EX mattresses because some of these products have been sold in close proximity, suggesting a potential intent for them to be used together. These products have not been tested for compatibility and thus are not designed to be used together. The combination of both is not recommended by Stryker. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 31, 2025device recall289d agoStryker Medical Division of Stryker Corporation device recall (Cls II)

    Stryker MV3 bariatric bed, Part Number 5900000001 — Reason: Stryker has issued a voluntary recall of certain MV3 beds and Arise 1000EX mattresses because some of these products have been sold in close proximity, suggesting a potential intent for them to be used together. These products have not been tested for compatibility and thus are not designed to be used together. The combination of both is not recommended by Stryker. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 31, 2025device recall289d agoPhilips North America Llc device recall (Cls II)

    IntelliVue Patient Monitor MX400. Product Number: 866060. — Reason: Potential issue where the IntelliVue monitors did not alarm. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 31, 2025device recall289d agoPhilips North America Llc device recall (Cls II)

    IntelliVue Multi-Measurement Module X3. Product Number: 867030. — Reason: Potential issue where the IntelliVue monitors did not alarm. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 31, 2025device recall289d agoAizu Olympus Co., Ltd. device recall (Cls II)

    Olympus OER-Pro — Reason: Inform existing affected device customers about pertinent Warnings/Cautions, existing recommended maintenance schedules and that only properly trained personnel conduct repairs and maintenance. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 31, 2025device recall289d agoPhilips North America Llc device recall (Cls II)

    IntelliVue Patient Monitor MX550. Product Number: 866066. — Reason: Potential issue where the IntelliVue monitors did not alarm. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 31, 2025device recall289d agoPhilips North America Llc device recall (Cls II)

    IntelliVue Patient Monitor MX750. Product Number: 866471. — Reason: Potential issue where the IntelliVue monitors did not alarm. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 31, 2025device recall289d agoAizu Olympus Co., Ltd. device recall (Cls II)

    Olympus OER-Mini — Reason: Inform existing affected device customers about pertinent Warnings/Cautions, existing recommended maintenance schedules and that only properly trained personnel conduct repairs and maintenance. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 31, 2025device recall289d agoPhilips North America Llc device recall (Cls II)

    IntelliVue Patient Monitor MX450. Product Number: 866062. — Reason: Potential issue where the IntelliVue monitors did not alarm. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 31, 2025device recall289d agoStryker Corporation device recall (Cls II)STRYKER CORP

    NICO Myriad Illumination Pack Product No. NN-1000 11g Illumination Sleeve/Fiber; Product No. NN-1001 13g Illumination Sleeve/Fiber — Reason: Tape used to secure components within packaging contains latex, despite products being labeled as latex-free. Latex could potentially cause an allergic reaction. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 31, 2025device recall289d agoPhilips North America Llc device recall (Cls II)

    IntelliVue MP70. Product Number: M8007A. — Reason: Potential issue where the IntelliVue monitors did not alarm. — Status: Ongoing

    full page →fda device recalls ↗
    ›Nov 1, 2025grant288d agoUNIVERSITY OF COLORADO DENVER — Enhancement of Effector CD8 Cell Motility through Mitochondrial MetabolismUniversity of Colorado Denver

    AI grant. $38,093. PI: Maureen E Hoen Rauhut

    full page →nih reporter ↗
    ›Nov 1, 2025grant288d agoYALE UNIVERSITY — Impact of Natural Infection on the Baseline Immune States in Humans

    AI grant. $34,558. PI: Yona Lei

    full page →nih reporter ↗
    ›Nov 1, 2025grant288d agoEMORY UNIVERSITY — Capsid assembly mechanisms of Kaposi Sarcoma associated herpesvirusEmory University

    AI grant. $78,052. PI: Shea Lowery

    full page →nih reporter ↗
    ›Nov 1, 2025grant288d agoPRINCETON UNIVERSITY — Molecular and Cellular Determinants of Tolerance to Second Generation Antipsy...

    MH grant. $33,538. PI: Elinor Lewis

    full page →nih reporter ↗
    ›Nov 1, 2025grant288d agoBROWN UNIVERSITY — TAC1 Tango: Evolutionary rewiring of a transcriptional circuit for azole drug...

    AI grant. $75,520. PI: Nicholas Cauldron

    full page →nih reporter ↗
    ›Nov 1, 2025grant288d agoMASSACHUSETTS GENERAL HOSPITAL — Antibody mediated immunity against Klebsiella pneumoniaeMassachusetts General Hospital

    AI grant. $19,000. PI: JASON B HARRIS

    full page →nih reporter ↗
    ›Nov 1, 2025grant288d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — Oral Microbiome Dysregulation as a Contributor to Depressive Symptoms and Alt...University of California Los Angeles

    MH grant. $42,489. PI: Naomi Gancz

    full page →nih reporter ↗
    ›Nov 1, 2025grant288d agoJOHNS HOPKINS UNIVERSITY — Microbiota mechanisms promoting Clostridioides difficile colon persistenceJohns Hopkins University

    AI grant. $49,538. PI: Hadley Beauregard

    full page →nih reporter ↗
    ›Nov 1, 2025grant288d agoHARVARD MEDICAL SCHOOL — Molecular Transport of IFT Complexes in Leishmania

    AI grant. $44,020. PI: Tierra Buck

    full page →nih reporter ↗
    ›Nov 1, 2025grant288d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — How does myelin plasticity influence neural circuit dynamics required for lon...University of California San Francisco

    MH grant. $75,052. PI: Manasi Iyer

    full page →nih reporter ↗
    ›Nov 1, 2025grant288d agoMASSACHUSETTS GENERAL HOSPITAL — Antibody mediated immunity against Klebsiella pneumoniaeMassachusetts General Hospital

    AI grant. $99,429. PI: JASON B HARRIS

    full page →nih reporter ↗
    ›Nov 1, 2025grant288d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Longitudinal Impact of Health and Lifestyle Behaviors on Cognition in Individ...

    HD grant. $75,600. PI: Michelle H Chen

    full page →nih reporter ↗
    ›Nov 1, 2025grant288d agoUNIVERSITY OF SOUTHERN CALIFORNIA — Syphilis Immunology and Biology to Improve Clinical Management and Vaccine De...University of Southern California

    AI grant. $238,136. PI: Jeffrey David Klausner

    full page →nih reporter ↗
    ›Nov 1, 2025grant288d agoUNIVERSITY OF TEXAS MED BR GALVESTON — Initiate Research, Opportunities, and Networks for Early Career Investigators...

    DK grant. $103,081. PI: Brittany L. Smalls

    full page →nih reporter ↗
    ›Nov 1, 2025grant288d agoNORTHWESTERN UNIVERSITY AT CHICAGO — Triggers of food allergen absorption and anaphylaxisNorthwestern University

    AI grant. $53,461. PI: Danielle Rose Jacobsen

    full page →nih reporter ↗
    ›Nov 1, 2025grant288d agoEMORY UNIVERSITY — Molecular determinants of Streptococcus pyogenes adhesion to pyroptotic kerat...Emory University

    AI grant. $49,538. PI: Jacob D Sherman

    full page →nih reporter ↗
    ›Nov 1, 2025grant288d agoVANDERBILT UNIVERSITY MEDICAL CENTER — All of Us Research Program Data and Research Center

    OD grant. $2,500,000. PI: Melissa Basford

    full page →nih reporter ↗
    ›Nov 1, 2025grant288d agoUNIVERSITY OF IOWA — Developing real-time personalized TMS to target residual corticospinal connec...University of Iowa

    NS grant. $245,687. PI: Sara J Hussain

    full page →nih reporter ↗
    ›Nov 1, 2025grant288d agoOHIO STATE UNIVERSITY — Epigenetic Regulation of KSHV

    AI grant. $85,360. PI: Kurtis Matthew Host

    full page →nih reporter ↗
    ›Nov 1, 2025grant288d agoJOHNS HOPKINS UNIVERSITY — Chemosensory Mechanisms Driving Malaria TransmissionJohns Hopkins University

    AI grant. $103,760. PI: Conor James McMeniman

    full page →nih reporter ↗
    ›Nov 1, 2025grant288d agoBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — 2025 Rachmiel Levine-Arthur Riggs Diabetes Research SymposiumCity of Hope

    DK grant. $20,000. PI: FOUAD R KANDEEL

    full page →nih reporter ↗
    ›Nov 1, 2025grant288d agoUNIVERSITY OF CALIFORNIA BERKELEY — Elucidating the mechanism and correlates of protection elicited by CDN adjuva...

    AI grant. $48,395. PI: Isabel Lamb-Echegaray

    full page →nih reporter ↗
    ›Nov 1, 2025grant288d agoST. JUDE CHILDREN'S RESEARCH HOSPITAL — Strategies and Consequences of Polymicrobial Nasal Colonization

    AI grant. $75,520. PI: Shyra Wilde

    full page →nih reporter ↗
    ›Nov 1, 2025grant288d agoSTANFORD UNIVERSITY — Predicting Japanese Encephalitis Spillover Risk in the United StatesStanford University

    AI grant. $75,052. PI: Rachel Lucy Fay

    full page →nih reporter ↗
    ›Nov 2, 2025device pma287d agoMicroVention, Inc. — Flow Re-Direction Endoluminal Device (FRED®) System (PMA supplement)MICROVISION, INC.

    Supplement type: Normal 180 Day Track No User Fee. Product code: OUT. Advisory committee: NE. Decision: APPR

    full page →fda device pma ↗
    ›Nov 2, 2025device recall287d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    MiniMed 780G Insulin Pump Catalog Numbers: MMT-1884 MMT-1886 With Software Version 6.60 The MiniMed 780G insulin pump is indicated for use by patients age 7-80 years with Type 1 diabetes, whose total daily dose of insulin is 8 units per day or more. The MiniMed 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin. The system is also intended to continuously monitor glucose values in the fluid under the skin. The MiniMed 780G system includes SmartGuard technology, which can be programmed to automatically adjust insulin delivery based on continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values. — Reason: A software timing and processor communication issue in MiniMed" 780G software version 6.60 may trigger Pump Error 43 and/or Pump Error 41, resulting in suspension of insulin delivery. — Status: Ongoing

    full page →fda device recalls ↗

    Week of Nov 3, 2025

    12
    ›Nov 3, 2025approval286d agoSTELARA (USTEKINUMAB) — FDA approvalJOHNSON & JOHNSON

    Sponsor: CENTOCOR ORTHO BIOTECH INC. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Nov 3, 2025approval
    ← prev
    page 25 of 286
    next →
    286d ago
    STELARA (USTEKINUMAB) — FDA approvalustekinumab

    Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

    full page →ustekinumab →fda approvals ↗
    ›Nov 3, 2025approval286d agoNIPENT (PENTOSTATIN) — FDA approvalpentostatin

    Sponsor: HOSPIRA INC. Form: INJECTABLE. Route: INJECTION

    full page →pentostatin →fda approvals ↗
    ›Nov 3, 2025approval286d agoBREXAFEMME (IBREXAFUNGERP CITRATE) — FDA approvalibrexafungerp citrate

    Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL

    full page →ibrexafungerp citrate →fda approvals ↗
    ›Nov 3, 2025approval286d agoCISATRACURIUM BESYLATE — FDA approvalCISATRACURIUM BESYLATE

    Sponsor: SAGENT PHARMS INC. Form: INJECTABLE. Route: INJECTION

    full page →CISATRACURIUM BESYLATE →fda approvals ↗
    ›Nov 3, 2025approval286d agoLINAGLIPTIN — FDA approvalLINAGLIPTIN

    Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

    full page →LINAGLIPTIN →fda approvals ↗
    ›Nov 3, 2025approval286d agoLINAGLIPTIN AND METFORMIN HYDROCHLORIDE (LINAGLIPTIN) — FDA approvalMSN Pharmaceuticals Inc

    Sponsor: DR REDDYS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 3, 2025approval286d agoLINAGLIPTIN — FDA approvalBoehringer Ingelheim Corp

    Sponsor: DR REDDYS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 3, 2025approval286d agoLINAGLIPTIN — FDA approvalLINAGLIPTIN

    Sponsor: MYLAN. Form: TABLET. Route: ORAL

    full page →LINAGLIPTIN →fda approvals ↗
    ›Nov 3, 2025approval286d agoLINAGLIPTIN — FDA approvalLINAGLIPTIN

    Sponsor: MSN. Form: TABLET. Route: ORAL

    full page →LINAGLIPTIN →fda approvals ↗
    ›Nov 3, 2025approval286d agoLINAGLIPTIN AND METFORMIN HYDROCHLORIDE (LINAGLIPTIN) — FDA approvalLINAGLIPTIN

    Sponsor: MSN. Form: TABLET. Route: ORAL

    full page →LINAGLIPTIN →fda approvals ↗
    ›Nov 3, 2025approval286d agoESLICARBAZEPINE ACETATE — FDA approvalShanghai Zhongxi Pharmaceutical Co Ltd

    Sponsor: SPH ZHONGXI PHARM. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    $SYK339.21-0.55%
    $MVIS2.2350-40.72%
    $JNJ260.35-0.66%